|
Jun 3
|
U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
|
|
May 22
|
Orion to host Capital Markets Day today, 22 May 2025, in Helsinki
|
|
May 21
|
Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers
|
|
May 2
|
Orion Corporation: Managers’ transactions – Ari Lehtoranta
|
|
May 2
|
Orion Corporation: Managers’ transactions – Hilpi Rautelin
|
|
May 2
|
Orion Corporation: Managers’ transactions – Eija Ronkainen
|
|
May 2
|
Orion Corporation: Managers’ transactions – Karen Lykke Sørensen
|
|
May 2
|
Orion Corporation: Managers’ transactions – Henrik Stenqvist
|
|
May 2
|
Orion Corporation: Managers’ transactions – Maziar Mike Doustdar
|
|
May 2
|
Orion Corporation: Managers’ transactions – Kari Jussi Aho
|
|
May 2
|
Orion Corporation: Managers’ transactions – Veli-Matti Mattila
|
|
May 2
|
301,521 Orion Corporation A shares converted into B shares
|
|
Mar 11
|
Orion Group Financial Statement documents 2024 and Remuneration Report published
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Julia Macharey
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Juhani Kankaanpää
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Hao Pan
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – René Lindell
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Olli Huotari
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Liisa Hurme
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Niclas Lindstedt
|